DK0759942T3 - Interleukin-15-receptorer - Google Patents

Interleukin-15-receptorer

Info

Publication number
DK0759942T3
DK0759942T3 DK95918389T DK95918389T DK0759942T3 DK 0759942 T3 DK0759942 T3 DK 0759942T3 DK 95918389 T DK95918389 T DK 95918389T DK 95918389 T DK95918389 T DK 95918389T DK 0759942 T3 DK0759942 T3 DK 0759942T3
Authority
DK
Denmark
Prior art keywords
interleukin
receptors
disclosed
dnas
receptor
Prior art date
Application number
DK95918389T
Other languages
Danish (da)
English (en)
Inventor
Judith G Giri
Dirk M Anderson
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of DK0759942T3 publication Critical patent/DK0759942T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
DK95918389T 1994-05-06 1995-05-04 Interleukin-15-receptorer DK0759942T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23691994A 1994-05-06 1994-05-06
US08/300,903 US5591630A (en) 1994-05-06 1994-09-06 Monoclonal antibodies that bind interleukin-15 receptors
PCT/US1995/005585 WO1995030695A1 (fr) 1994-05-06 1995-05-04 Recepteurs de l'interleukine-15

Publications (1)

Publication Number Publication Date
DK0759942T3 true DK0759942T3 (da) 2003-06-10

Family

ID=26930223

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95918389T DK0759942T3 (da) 1994-05-06 1995-05-04 Interleukin-15-receptorer

Country Status (11)

Country Link
US (1) US5591630A (fr)
EP (1) EP0759942B1 (fr)
AT (1) ATE233788T1 (fr)
AU (1) AU695798B2 (fr)
CA (1) CA2188279C (fr)
DE (1) DE69529822T2 (fr)
DK (1) DK0759942T3 (fr)
ES (1) ES2193192T3 (fr)
NZ (1) NZ285292A (fr)
PT (1) PT759942E (fr)
WO (1) WO1995030695A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548065B1 (en) * 1994-05-06 2003-04-15 Immunex Corporation Interleukin-15 receptors
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
AU729515B2 (en) * 1996-10-17 2001-02-01 Immunomedics Inc. Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
EP0971728B1 (fr) * 1997-02-21 2002-12-11 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Utilisation de l' interleukine-15
US20030013668A1 (en) * 1998-07-07 2003-01-16 Dange Veerapanane Ph.D Antisense oligonucleotides targeted to il-15
AU4542801A (en) * 2000-03-03 2001-09-17 Univ Utah Res Found Mass1 gene, a target for anticonvulsant drug development
AU2002332628B2 (en) * 2001-08-23 2007-07-26 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
US7247304B2 (en) * 2001-08-23 2007-07-24 Genmab A/S Methods of treating using anti-IL-15 antibodies
US7329405B2 (en) * 2001-08-23 2008-02-12 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
MX2007014474A (es) 2005-05-17 2008-02-07 Univ Connecticut Composiciones y metodos para inmunomodulacion en un organismo.
EP1777294A1 (fr) 2005-10-20 2007-04-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Le domaine sushi de IL-15Ralpha comme enhancer sélectif et efficace de l'action de f IL-15 grâce à IL-15Rbeta/gamma, et l' hyperagoniste (IL15Ralpha sushi -IL15) comme protéine fusion
NZ569541A (en) 2006-01-13 2012-05-25 Us Gov Health & Human Serv Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
NZ599338A (en) 2007-06-27 2013-11-29 Marinepolymer Tech Inc Complexes of il-15 and il-15ralpha and uses thereof
CA2768965C (fr) 2009-08-14 2019-06-04 George N. Pavlakis Utilisation d'il-15 pour ameliorer la production thymique et pour traiter la lymphopenie
WO2011031986A1 (fr) 2009-09-10 2011-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Office Of Technology Transfer, National Institutes Of Health Dosages du récepteur soluble à il-15 alpha
AU2013334610B2 (en) 2012-10-24 2018-09-13 Novartis Ag IL-15R alpha forms, cells expressing IL-15R alpha forms, and therapeutic uses of IL-15R alpha and IL-15/IL-15R alpha complexes
DK2986312T3 (da) 2013-04-19 2022-02-14 Cytune Pharma Cytokinafledt behandling med reduceret vaskulært lækagesyndrom
ES2811974T3 (es) 2014-07-29 2021-03-15 Novartis Ag Regímenes de aumento escalonado de la dosis del heterodímero de il-15 e il-15ralfa para tratar afecciones
AU2017283480A1 (en) 2016-06-13 2019-01-24 Torque Therapeutics, Inc. Methods and compositions for promoting immune cell function
EP3678701A4 (fr) 2017-09-05 2021-12-01 Torque Therapeutics, Inc. Compositions protéiques thérapeutiques et procédés de préparation et d'utilisation de celles-ci
CN112795543B (zh) * 2021-02-04 2022-09-27 华中农业大学 杂交瘤细胞株及其分泌的抗草鱼IL-15Rα单克隆抗体和应用
WO2024040132A2 (fr) 2022-08-16 2024-02-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic Interactions synergiques pour traitement anticancéreux amélioré

Also Published As

Publication number Publication date
EP0759942B1 (fr) 2003-03-05
DE69529822D1 (de) 2003-04-10
DE69529822T2 (de) 2003-12-11
AU2434495A (en) 1995-11-29
AU695798B2 (en) 1998-08-20
EP0759942A4 (fr) 1999-05-12
ATE233788T1 (de) 2003-03-15
PT759942E (pt) 2003-07-31
ES2193192T3 (es) 2003-11-01
EP0759942A1 (fr) 1997-03-05
CA2188279A1 (fr) 1995-11-16
US5591630A (en) 1997-01-07
NZ285292A (en) 1998-08-26
CA2188279C (fr) 2010-01-26
WO1995030695A1 (fr) 1995-11-16

Similar Documents

Publication Publication Date Title
ATE233788T1 (de) Interleukin-15-rezeptoren
LU90591I2 (fr) Enbrel-etanercept
DK0460846T3 (da) Type II interleukin-1-receptorer
IL152414A0 (en) Mammalian cytokine receptor subunit proteins, related reagents and methods
UA41888C2 (uk) Злитий білок, який складається з мишачого або олюдненого моноклонального антитіла мав425 або його фрагменту, який спрямовано проти пухлинної клітини, спосіб його отримання, фармацевтична композиція
EP0318296A3 (fr) Récepteurs d'interleukine-1
EA200000216A1 (ru) Белки, связывающие интерлейкин-18, их получение и применение
DK0673420T3 (da) Mammale receptorer for interleukin 10 (IL-10)
ATE118036T1 (de) Interleukin-7-rezeptoren.
EP2292760A3 (fr) Cytokines de mammifères, récepteurs, réactifs correspondants et méthodes
WO2001036467A3 (fr) Proteines de recepteurs mammaliens, reactifs et procedes s'y rapportant
PT1181366E (pt) Proteínas receptoras de mamífero; reagentes e métodos relacionados
ATE58172T1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
NZ515382A (en) OX2 receptor homologs
ATE123812T1 (de) Rezeptoren für granulozytenkolonien stimulierenden faktor.
HUP9801062A2 (hu) Új PKA-kötődő fehérjék, és ezek alkalmazása
CY1114280T1 (el) Αντισωματα ανταγωνιστων των κυτοκινων θηλαστικων ή οι υποδοχεις τους για την αγωγη της αλλεργιας